Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

5195 ARTÍCULOS , VIENDO DEL 616 AL 630

A cornerstone initiative for progress in Parkinson's disease

The Lancet Neurology.

Lancet Neurol. 2020 Jan;19(1):1. doi: 10.1016/S1474-4422(19)30432-6.

Allogeneic HSCT for adult-onset leukoencephalopathy with spheroids and pigmented glia

Gelfand JM, Greenfield AL, Barkovich M, Mendelsohn BA, Van Haren K, Hess CP, Mannis GN.

Brain. 2020 Feb 1;143(2):503-511. doi: 10.1093/brain/awz390.

The Narrowing Path for Nilotinib and Other Potential Disease-Modifying Therapies for Parkinson Disease

Espay AJ, Hauser RA, Armstrong MJ.

JAMA Neurol. 2020 Mar 1;77(3):295-297. doi: 10.1001/jamaneurol.2019.3983.

Nilotinib Effects on Safety, Tolerability, and Potential Biomarkers in Parkinson Disease: A Phase 2 Randomized Clinical Trial

Pagan FL, Hebron ML, Wilmarth B, Torres-Yaghi Y, Lawler A, Mundel EE, Yusuf N, Starr NJ, Anjum M, Arellano J, Howard HH, Shi W, Mulki S, Kurd-Misto T, Matar S, Liu X, Ahn J, Moussa C.

JAMA Neurol. 2020 Mar 1;77(3):309-317. doi: 10.1001/jamaneurol.2019.4200.

The Horizon of Gene Therapy in Modern Medicine: Advances and Challenges

Arjmand B, Larijani B, Sheikh Hosseini M, Payab M, Gilany K, Goodarzi P, Parhizkar Roudsari P, Amanollahi Baharvand M, Hoseini Mohammadi NS.

Adv Exp Med Biol. 2020;1247:33-64. doi: 10.1007/5584_2019_463.

The gut in Parkinson's disease: Bottom-up, top-down, or neither?

Leclair-Visonneau L, Neunlist M, Derkinderen P, Lebouvier T.

Neurogastroenterol Motil. 2020 Jan;32(1):e13777. doi: 10.1111/nmo.13777.

Determinants of Low Body Mass Index in Patients with Parkinson's Disease: A Multicenter Case-Control Study

Suzuki K, Okuma Y, Uchiyama T, Miyamoto M, Haruyama Y, Kobashi G, Sakakibara R, Shimo Y, Hatano T, Hattori N, Yamamoto T, Hirano S, Yamamoto T, Kuwabara S, Kaji Y, Fujita H, Kadowaki T, Hirata K.

J Parkinsons Dis. 2020;10(1):213-221. doi: 10.3233/JPD-191741.

Ethnic Variation in the Manifestation of Parkinson's Disease: A Narrative Review

Ben-Joseph A, Marshall CR, Lees AJ, Noyce AJ.

J Parkinsons Dis. 2020;10(1):31-45. doi: 10.3233/JPD-191763.

The Minimal Clinically Relevant Change of the FOG Score

Fietzek UM, Schulz SJ, Ziegler K, Ceballos-Baumann AO.

J Parkinsons Dis. 2020;10(1):325-332. doi: 10.3233/JPD-191783.

Invited Review: The role of prion-like mechanisms in neurodegenerative diseases

Jaunmuktane Z, Brandner S.

Neuropathol Appl Neurobiol. 2020 Oct;46(6):522-545. doi: 10.1111/nan.12592. Epub 2020 Feb 11.

What predicts quality of life after subthalamic deep brain stimulation in Parkinson's disease? A systematic review

Geraedts VJ, Feleus S, Marinus J, van Hilten JJ, Contarino MF.

Eur J Neurol. 2020 Mar;27(3):419-428. doi: 10.1111/ene.14147. Epub 2020 Jan 24.

Association of Intestinal Disorders with Parkinson's Disease and Alzheimer's Disease: A Systematic Review and Meta-Analysis

Fu P, Gao M, Yung KKL.

ACS Chem Neurosci. 2020 Feb 5;11(3):395-405. doi: 10.1021/acschemneuro.9b00607. Epub 2020 Jan 8.

Multimodal Balance Training Supported by Rhythmical Auditory Stimuli in Parkinson's Disease: A Randomized Clinical Trial

Capato TTC, de Vries NM, IntHout J, Barbosa ER, Nonnekes J, Bloem BR.

J Parkinsons Dis. 2020;10(1):333-346. doi: 10.3233/JPD-191752.

Balancing contested meanings of creativity and pathology in Parkinson’s Disease

Porter D.

In: Jackson M, Moore MD, editors. Balancing the self: Medicine, politics and the regulation of health in the twentieth century [Internet]. Manchester (UK): Manchester University Press; 2020. Chapter 10.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias